CN107125751A - Tortoise powder, preparation method and applications - Google Patents
Tortoise powder, preparation method and applications Download PDFInfo
- Publication number
- CN107125751A CN107125751A CN201710389829.9A CN201710389829A CN107125751A CN 107125751 A CN107125751 A CN 107125751A CN 201710389829 A CN201710389829 A CN 201710389829A CN 107125751 A CN107125751 A CN 107125751A
- Authority
- CN
- China
- Prior art keywords
- parts
- tortoise
- powder
- root
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000270708 Testudinidae Species 0.000 title claims abstract description 146
- 239000000843 powder Substances 0.000 title claims abstract description 116
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 29
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 29
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 28
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 27
- 239000009636 Huang Qi Substances 0.000 claims abstract description 27
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 27
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 27
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 27
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 27
- 235000008397 ginger Nutrition 0.000 claims abstract description 27
- 235000005412 red sage Nutrition 0.000 claims abstract description 27
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 26
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 25
- 244000241872 Lycium chinense Species 0.000 claims abstract description 24
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 24
- 244000273928 Zingiber officinale Species 0.000 claims abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 239000012634 fragment Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 54
- 238000000034 method Methods 0.000 abstract description 23
- 230000002929 anti-fatigue Effects 0.000 abstract description 20
- 230000036039 immunity Effects 0.000 abstract description 15
- 230000036541 health Effects 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 6
- 235000008935 nutritious Nutrition 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 4
- 235000012041 food component Nutrition 0.000 abstract description 3
- 238000009434 installation Methods 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 29
- 241000234314 Zingiber Species 0.000 description 23
- 239000008280 blood Substances 0.000 description 18
- 230000037396 body weight Effects 0.000 description 18
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 9
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- -1 coumarin glucoside Chemical class 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GTLGHKNKLRZSMO-UHFFFAOYSA-N 4-(3-hydroxybutyl)-2-methoxyphenol Chemical compound COC1=CC(CCC(C)O)=CC=C1O GTLGHKNKLRZSMO-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 235000002710 Ilex cornuta Nutrition 0.000 description 2
- 241001310146 Ilex cornuta Species 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- JGUQDUKBUKFFRO-GGWOSOGESA-N (NE)-N-[(3E)-3-hydroxyiminobutan-2-ylidene]hydroxylamine Chemical compound O\N=C(/C)\C(\C)=N\O JGUQDUKBUKFFRO-GGWOSOGESA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to nutrition and health care technical field, and in particular to a kind of tortoise powder, preparation method and applications.The tortoise powder that the present invention is provided is using tortoise as major ingredient, and selected kinds of traditional Chinese medicines, including ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis, contain multiple nutritional components, acted on by coordinated each other, reach improvement human body constitution, improve immunity, antifatigue effect.The preparation method of the tortoise powder provided is invented, process is simple, it is not necessary to which special installation can farthest retain the medicinal efficacy of each taste raw material.The tortoise powder that the present invention is provided can be used for individually being packaged into pulvis, can directly use, it can also be used to nutritious, it is possible to increase body immunity in terms of making cake and Baoshang, antifatigue.
Description
Technical field
The present invention relates to nutrition and health care technical field, more particularly to a kind of tortoise powder, preparation method and applications.
Background technology
As rhythm of life is constantly accelerated, various competitions increasingly sharpen, and life stress is more and more heavier, the body of majority
All in sub-health state, body is apprehensive, easily fatigue.In addition, as the age increases, the elderly's physical function aging, organ
Function constantly declines, and easily triggers various diseases.With the improvement of people ' s living standards and to healthy attention, the health care of nourishing
Nutriment also comes more by people to be favored.
Tortoise is traditional dietotherapy tonic, and its medical value is on the books very early in China.Physician's Li Shizhen (1518-1593 A.D.) institute of the Ming Dynasty
Write《Compendium of Materia Medica》In write：" cyprid 360, and tortoise is long for it.Tortoise, the spirit elder of cyprid ".Tortoise is regarded as food
The top grade mended and built up one's health by taking tonic.
The nutritive value of tortoise is very high, and nature and flavor are sweet, sour, flat, containing protein, fat, nicotinic acid, vitamin B1, B2, colloid etc.
Nutritional ingredient, have functions that enriching yin and nourishing kidney, soft liver enrich blood, fiery improving eyesight of dispelling.Tortoise albumen is easily absorbed by human body, can strengthen and exempt from
Epidemic disease function, to promoting health and preventing cancer important role.The effect of tortoise meat has blood-nourishing blood-generating, nourishing YIN for benefiting the kidney, help
Power is strong, is of high nutritive value, to various tumour yin deficiency deficiency of blood persons and chronic cough, spitting of blood, dysphoria and insomnia, the enuresis, anal fistula, arthralgia and myalgia etc.
Chronic disease has certain curative effect.
There are some using tortoise as the health products of raw material in the market, but its composition is single, and its effect is limited to, hypotrophy
Face, effect is not good.
In view of this, the present invention is proposed.
The content of the invention
The first object of the present invention is to provide a kind of tortoise powder, using tortoise as major ingredient, and selected kinds of traditional Chinese medicines, including spirit
Sesame, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis, containing multiple nutritional components, by each other
Coordinated is acted on, and is reached improvement human body constitution, is improved immunity, antifatigue effect.
The second object of the present invention is to provide a kind of preparation method of tortoise powder, and the process is simple, it is not necessary to special
Equipment can farthest retain the medicinal efficacy of each taste raw material.
The third object of the present invention is to provide a kind of application of above-mentioned tortoise powder, available for being individually packaged into pulvis, can be with
Directly use, it can also be used to nutritious, it is possible to increase body immunity in terms of making cake and Baoshang, it is antifatigue.
To achieve the above object, the technical solution adopted by the present invention is：
A kind of tortoise powder, including the following raw material counted by weight：60-80 parts of tortoise, 5-15 parts of ganoderma lucidum, 2-8 parts of the root of kudzu vine,
1-2 parts of 2-8 parts of ginger, 1-5 parts of the fruit of Chinese wolfberry, 1-3 parts of the red sage root, 1-3 parts of pseudo-ginseng, 1-3 parts of the Radix Astragali and cordyceps sinensis.
Further, the tortoise powder includes the following raw material counted by weight：65-75 parts of tortoise, 7-13 parts of ganoderma lucidum, Pueraria lobota
1-2 parts of 3-7 parts of root, 3-7 parts of ginger, 2-4 parts of the fruit of Chinese wolfberry, 1-3 parts of the red sage root, 1-3 parts of pseudo-ginseng, 1-3 parts of the Radix Astragali and cordyceps sinensis.
Preferably, the tortoise powder includes the following raw material counted by weight：70 parts of tortoise, 10 parts of ganoderma lucidum, 5 parts of the root of kudzu vine,
1 part of 5 parts of ginger, 3 parts of the fruit of Chinese wolfberry, 2 parts of the red sage root, 2 parts of pseudo-ginseng, 2 parts of the Radix Astragali and cordyceps sinensis.
The preparation method of above-mentioned tortoise powder, comprises the following steps：
(a) tortoise living is supported 5-7 days with clear water, cleaned up, and be ground into 2-4cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water, are obtained dope；
(e) it is dried at 80-90 DEG C；
(f) 80-150 mesh powders are ground into by dried.
Further, the time is boiled in step (c) for 36-48 hours.
Further, the time is boiled in step (d) for 60-90 minutes.
Further, drying time is 24-36 hours in step (e).
The powder that step (f) is made is added after preservative and packed.
Application of the above-mentioned tortoise powder in terms of nourishing pastry is prepared.
Application of the above-mentioned tortoise powder in terms of Baoshang is prepared.
Compared with prior art, the beneficial effects of the present invention are：
1. the tortoise powder that the present invention is provided, using tortoise as major ingredient, and selected kinds of traditional Chinese medicines, including ganoderma lucidum, the root of kudzu vine, ginger, Chinese holly
Matrimony vine, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis, containing multiple nutritional components, are acted on by coordinated each other, reached
To improvement human body constitution, improve immunity, antifatigue effect.
2. the preparation method for the tortoise powder that the present invention is provided, process is simple, it is not necessary to which special installation can be at utmost
Ground retains the medicinal efficacy of each taste raw material.
3. the tortoise powder that the present invention is provided can be used for individually being packaged into pulvis, can directly it use, it can also be used to make cake
It is nutritious in terms of Baoshang, it is possible to increase body immunity, it is antifatigue.
Embodiment
Technical scheme is clearly and completely described below in conjunction with embodiment, it is clear that described reality
It is a part of embodiment of the invention to apply example, rather than whole embodiments.Based on the embodiment in the present invention, the common skill in this area
The every other embodiment that art personnel are obtained under the premise of creative work is not made, belongs to the model that the present invention is protected
Enclose.
Tortoise, is a kind of medicinal and edibility all very high nourishing top grades.According to Historical Data Data About, the various pieces of tortoise have
Very high value.
Tortoise meat, it is nutritious, containing abundant protein, mineral matter etc..The traditional Chinese medical science is recorded, and tortoise meat flat property and sweet taste is salty, channel tropism liver,
Kidney, large intestine three are passed through, and have effects that blood-nourishing blood-generating, nourishing YIN for benefiting the kidney, cure mainly the deficiency of liver-yin and kidney-yin, deficiency of YIN-blood, blood and essence asthenia, thin tired
The disease such as power, long paralysed impotence be weak.Modern medicine believes that, tortoise albumen has certain antitumaous effect, tumour cell can be suppressed, and can strengthen
Body's immunity.
Tortoise blood, the traditional Chinese medical science is recorded, and the cold taste of tortoise courage and uprightness is salty, and Return liver, kidney two warp have effects that blood-nourishing and network, cure mainly liver kidney yin
The diseases such as void, deficiency of YIN-blood, traumatic injury, prolapse of the anus.
Tortoiseshell, is the plastron and carapace of tortoise, and it is rich in ossein and protein, calcium, phosphorus, lipid, peptides and a variety of enzymes.
The traditional Chinese medical science is recorded, and tortoiseshell is cold in nature, and sweet-salty, Return liver, kidney, the heart three are passed through, the work(with nourishing and suppressing Yang, replenishing kidney and strengthening bone and blood-nourishing bushing
Effect, the treatment deficiency of the kidney yin, hectic fever due to yin labor heat, haematemesiss, bleeding from five sense organs or subcutaneous tissue, chronic cough, seminal emission, uterine bleeding, with, it is pain in the back, the atrophic debility of bones, wind formation from yin deficiency, long
Dysentery, chronic malaria and hemorrhoid.Modern medicine believes that, tortoiseshell contains ossein, wherein have several amino acids, steroid and calcium, phosphorus etc.,
Extract can suppress tumour cell, have therapeutic action to ascitic type liver cancer.
The present invention, tortoise uses full tortoise, makes full use of the nutritive value of tortoise various pieces.
In the present invention, tortoise is typical but non-limiting number is：60 parts, 61 parts, 62 parts, 63 parts, 64 parts, 65 parts, 66 parts,
67 parts, 68 parts, 69 parts, 70 parts, 71 parts, 72 parts, 73 parts, 74 parts, 75 parts, 76 parts, 77 parts, 78 parts, 79 parts or 80 parts.
Ganoderma lucidum, is the fructification of On Polyporaceae ganoderma lucidum；It is mild-natured, it is sweet；The thoughts of returning home, lung, liver and kidney channel；With tonifying Qi peace
Effect that is refreshing, relieving cough and asthma, promoting longevity；For treating the diseases such as dizziness egersis, palpitation, neurasthenia, consumptive disease cough and asthma.Spirit
Sesame is strengthening by means of tonics, consolidates the precious Chinese herbal medicine of righting, it is main containing amino acid, polypeptide, protein, fungal lysozyme and carbohydrate,
Ergosterol, triterpenes, coumarin glucoside, volatile oil, stearic acid, benzoic acid, alkaloid, vitamin B2 and C etc.；Spore is also containing sweet
Reveal alcohol, trehalose etc..Modern medicine believes that, ganoderma lucidum contains several physiological active substances, it can adjust and strengthen body immunity,
There is good synergistic therapeutic action to neurasthenia, rheumatic arthritis, coronary heart disease, hypertension, hepatitis, diabetes, tumour etc..
In the present invention, ganoderma lucidum is typical but non-limiting number is：5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts,
13 parts, 14 parts or 15 parts.
The root of kudzu vine, is the dry root of legume pueraria lobata；It is cool in nature, it is sweet, pungent；Brought down a fever with expelling pathogenic factors from muscles and skin, promoting eruption, promote the production of body fluid to quench thirst,
Effect of Shengyang Zhixie；For treat exterior syndrome heating, stiff nape and back, measles without adequate eruption, pyreticosis is thirsty, the deficiency of Yin is quenched one's thirst, heat is purged heat dysentery,
The diseases such as splenasthenic diarrhea.《Bencao Jingshu》Described in, " root of kudzu vine, dismisses the positive bright main medicine of warm disease heat evil, therefore master quenches one's thirst, high fever of the body,
Heat is stopped up chest diaphragm and vomitted.Dissipate and rise, the property of expelling wind drug, therefore main all numbness." main component of the root of kudzu vine is starch, additionally contain
About 12% flavone compound, including daizeol, daidzin and Puerarin etc. more than 10 are planted；And contain Daucosterol, ammonia
Base acid, Coumarins etc..The root of kudzu vine can hypotensive, and can coronary artery dilator, increase the CBF of coronary vasodilator, can be pre-
Anti- and improvement diabetes, hypertension, high fat of blood, cardio-cerebrovascular diseases.
In the present invention, the root of kudzu vine is typical but non-limiting number is：2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts or 8 parts.
Ginger, is the new fresh quench stem of zingiber；It is slightly warm in nature, pungent；Return lung, spleen, stomach；With relieving exterior syndrome and dispelling cold, temperature
Middle preventing or arresting vomiting, effect of preventing phlegm from forming and stopping coughing；The disease such as coughed for alleviating sputum cough, anemofrigid cold, gastrofrigid vomiting, cold productive cough.Modern times doctor
Think that ginger zingerone containing volatility and zingerol have the functions such as promoting blood circulation, dispelling cold, dehumidifying, sweating, can also arresting vomiting by using stomachics, ward off
Stench, consumer edema.
In the present invention, ginger is typical but non-limiting number is：2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts or 8 parts.
The fruit of Chinese wolfberry, is the dry mature fruit of plant of Solanaceae lycium barbarum；It is mild-natured, sweet；Return liver and kidney channel；With nourishing
Liver kidney, effect of benefiting shrewd head, for alleviating consumption consumptive loss, soreness of waist and knee joint, dizziness and tinnitus, Heat Diabetes, blood deficiency chlorosis, blurred vision
It is not clear to wait disease.《Dietetic materia medica》" hard muscle it is resistance to it is old, except wind, help muscles and bones, can beneficial people, remove consumptive disease.”
In the present invention, the fruit of Chinese wolfberry is typical but non-limiting number is：1 part, 2 parts, 3 parts, 4 parts or 5 parts.
The red sage root, is the drying root and rhizome of the labiate red sage root；Cold nature, bitter；The thoughts of returning home, Liver Channel；Stop with dissolving stasis
Bitterly, invigorate blood circulation, effect of relieving restlessness that clears away heart-fire；For alleviate irregular menstruation, closed dysmenorrhea, a lump in the abdomen causing distension and pain, sore swell and ache curative, it is vexed not
The diseases such as dormancy.
In the present invention, the red sage root is typical but non-limiting number is：1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts.
Pseudo-ginseng, is the dry root of panax araliaceae plant；Warm-natured, sweet, slight bitter；Return liver, stomach；With dissipate stasis of blood hemostasis,
Effect of detumescence ding-tong；For alleviate spitting of blood, haematemesis, bleeding from five sense organs or subcutaneous tissue, have blood in stool, uterine bleeding, traumatism and bleeding, chest and abdomen are twinged, tumbling and swelling etc.
Disease.Modern medicine believes that, pseudo-ginseng has regulation immune and antineoplastic action, angiocardiopathy can also be prevented and treated.
In the present invention, pseudo-ginseng is typical but non-limiting number is：1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts.
The Radix Astragali, is the dry root of legume astragalus mongolicus or Astragalus membranacus；It is warm-natured, sweet；Return lung, the spleen channel；With benefit
Superficies-consolidating, inducing diuresis for removing edema, effect of promoting pus discharge and tissue regeneration；For alleviate treatment deficiency of vital energy weak, exterior deficiency spontaneous perspiration, blood-arthralgia, edema, ulcer is difficult to burst,
The diseases such as Heat Diabetes.Modern medicine thinks that there is the Radix Astragali reduction blood viscosity, bidirectional modulation blood glucose, cardiac stimulant shield heart, diuresis to protect
Kidney, anti-aging, anti anoxia, antitumor, enhancing immunity of organisms effect.
In the present invention, the Radix Astragali is typical but non-limiting number is：1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts.
Cordyceps sinensis is the stroma and larva that section ergot fungus cordyceps sinensis bacterium is colonized on Hepialidae insect larvae
The complex of corpse；It is mild-natured, sweet；Return lung, kidney channel；Have effects that to invigorate the lung and the kidney, hemostasis and phlegm；It is empty for alleviating chronic cough
Breathe heavily, overstrain cough spitting of blood, impotence and seminal emission, soreness of waist and knee joint.《The new compilation of materia medica》Described in " protect lung kidney-nourishing, hemostasis and phlegm, overstrain cough." modern
Medical science similarly thinks that cordyceps sinensis has effects that kidney tonifying, moistening lung, anti-inflammatory anticancer.
In the present invention, cordyceps sinensis is typical but non-limiting number is：1 part, 1.5 parts or 2 parts.
It should be noted that the good beneficial effect of the tortoise powder of the present invention is determined by its specific raw material components and proportioning
Fixed, if component and its not mutually coordinated, the beneficial effect that single component is brought of proportioning, it is likely that can be cut down by other components
Even eliminate, do not have whole synthesis effect.The present invention is by substantial amounts of research and verifies repeatedly, has obtained the optimal set of tortoise powder
Close and match so that multiple components combine, mutually coordinated, the positive synergy of generation, reach improvement human body constitution, carry
High immunity, antifatigue effect.The raising immunity and antifatigue effect of the tortoise powder of the present invention will be carried out in detail below
It is thin to introduce.
The preparation method of above-mentioned tortoise powder, comprises the following steps：
(a) tortoise living is supported 5-7 days with clear water, cleaned up, and be ground into 2-4cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water, are obtained dope；
(e) it is dried at 80-90 DEG C；
(f) 80-150 mesh powders are ground into by dried.
In the present invention, step (a) is full tortoise, is supported 5-7 days with clear water, water free from admixture into water is changed in decontamination daily.
In the present invention, step (b) is respectively by ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis
Powder is made, it is standby, it is that other raw materials are made into powder is easily handled tortoise oil because tortoise is boiling many tortoises oil of later stage generation,
Facilitate the later stage without legal system powder.
In the present invention, step (c) boils tortoise fragment in 95-100 DEG C of water；The time is boiled for 36-48 hours, makes crow
Tortoise is thoroughly made ripe.
The time is boiled in step (c) typical but non-limiting be：36 hours, 37 hours, 38 hours, 39 hours, 40 hours,
41 hours, 42 hours, 43 hours, 44 hours, 45 hours, 46 hours, 47 hours or 48 hours.
In the present invention, step (d) adds other raw material powder, is boiled in 80-90 DEG C of water, obtains dope；Boil the time
For 60-90 minutes, make the active ingredient of each taste raw material all boil out, interact.
The time is boiled in step (d) typical but non-limiting be：60 minutes, 65 minutes, 70 minutes, 75 minutes, 80 minutes,
85 minutes or 90 minutes.
In the present invention, step (e) is dried at 80-90 DEG C, and drying time is 24-36 hours；
Drying time is typical in step (e) but non-limiting is：24 hours, 25 hours, 26 hours, 27 hours, 28 hours,
29 hours, 30 hours, 31 hours, 32 hours, 33 hours, 34 hours, 35 hours or 36 hours.
In the present invention, the powder that can also include step (f) being made adds packaging after preservative.
The preparation method for the tortoise powder that the present invention is provided, process is simple, it is not necessary to which special installation can be farthest
Retain the medicinal efficacy of each taste raw material.
Above-mentioned tortoise powder can be used directly, it can also be used to make cake and Baoshang etc. available for individually pulvis is packaged into
Aspect, it is nutritious, it is possible to increase body immunity, it is antifatigue.
In order to which present disclosure is explained further, it is introduced with reference to specific embodiment.
Embodiment 1
The tortoise powder of embodiment 1, including the following raw material counted by weight：70 parts of tortoise, 10 parts of ganoderma lucidum, 5 parts of the root of kudzu vine, life
1 part of 5 parts of ginger, 3 parts of the fruit of Chinese wolfberry, 2 parts of the red sage root, 2 parts of pseudo-ginseng, 2 parts of the Radix Astragali and cordyceps sinensis.
Prepare by the following method：
(a) tortoise living is supported 6 days with clear water, cleaned up, and be ground into 3cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled 42 hours in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water 75 minutes, are obtained dope；
(e) it is dried at 80-90 DEG C 30 hours；
(f) 80-150 mesh powders are ground into by dried.
Embodiment 2
The tortoise powder of embodiment 2, including the following raw material counted by weight：65 parts of tortoise, 13 parts of ganoderma lucidum, 3 parts of the root of kudzu vine, life
1 part of 7 parts of ginger, 2 parts of the fruit of Chinese wolfberry, 3 parts of the red sage root, 1 part of pseudo-ginseng, 3 parts of the Radix Astragali and cordyceps sinensis.
Prepared according to the method in embodiment 1.
Embodiment 3
The tortoise powder of embodiment 3, including the following raw material counted by weight：75 parts of tortoise, 7 parts of ganoderma lucidum, 7 parts of the root of kudzu vine, life
2 parts of 3 parts of ginger, 4 parts of the fruit of Chinese wolfberry, 1 part of the red sage root, 3 parts of pseudo-ginseng, 1 part of the Radix Astragali and cordyceps sinensis.
Prepared according to the method in embodiment 1.
Embodiment 4
The tortoise powder of embodiment 4, including the following raw material counted by weight：60 parts of tortoise, 15 parts of ganoderma lucidum, 5 parts of the root of kudzu vine, life
1 part of 5 parts of ginger, 3 parts of the fruit of Chinese wolfberry, 2 parts of the red sage root, 2 parts of pseudo-ginseng, 2 parts of the Radix Astragali and cordyceps sinensis.
Prepare by the following method：
(a) tortoise living is supported 7 days with clear water, cleaned up, and be ground into 4cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled 48 hours in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water 90 minutes, are obtained dope；
(e) it is dried at 80-90 DEG C 24 hours；
(f) 80-150 mesh powders are ground into by dried.
Embodiment 5
The tortoise powder of embodiment 5, including the following raw material counted by weight：80 parts of tortoise, 5 parts of ganoderma lucidum, 5 parts of the root of kudzu vine, life
1 part of 5 parts of ginger, 3 parts of the fruit of Chinese wolfberry, 2 parts of the red sage root, 2 parts of pseudo-ginseng, 2 parts of the Radix Astragali and cordyceps sinensis.
Prepare by the following method：
(a) tortoise living is supported 5 days with clear water, cleaned up, and be ground into 2cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled 36 hours in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water 60 minutes, are obtained dope；
(e) it is dried at 80-90 DEG C 36 hours；
(f) 80-150 mesh powders are ground into by dried.
Comparative example 1
The tortoise powder of comparative example 1, including the following raw material counted by weight：40 parts of tortoise, 25 parts of ganoderma lucidum, 10 parts of the root of kudzu vine,
1 part of 7 parts of ginger, 2 parts of the fruit of Chinese wolfberry, 8 parts of the red sage root, 6 parts of pseudo-ginseng, 5 parts of the Radix Astragali and cordyceps sinensis.
Prepared according to the method in embodiment 1.
Comparative example 2
The tortoise powder of comparative example 2, including the following raw material counted by weight：90 parts of tortoise, 3 parts of ganoderma lucidum, 1 part of the root of kudzu vine, life
1 part of 1 part of ginger, 2 parts of the fruit of Chinese wolfberry, 3 parts of the red sage root, 1 part of pseudo-ginseng, 3 parts of the Radix Astragali and cordyceps sinensis.
Prepared according to the method in embodiment 1.
Comparative example 3
The tortoise powder of comparative example 3, raw material composition be the same as Example 1.
It is prepared by the following method：
Tortoise living is supported 6 days with clear water, cleaned up, and be ground into 6cm fragment；By tortoise, ganoderma lucidum, the root of kudzu vine, ginger, Chinese holly
Matrimony vine, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis are added in 95-100 DEG C of water by weight to be boiled 20 hours, obtains sticky
Thing；It is dried at 80-90 DEG C 42 hours, and is ground into 80-150 mesh powders.
The immunological regulation of the tortoise powder provided with reference to effect example 1 and effect example 2 embodiment of the present invention 1 and antifatigue work
With being introduced.
The immunoregulation effect of the tortoise powder of effect example 1
1.1 animal subject：Kunming mouse body weight 20-25g
1.2 test method：Press《Function of health food assessment process and the method for inspection》Carry out.
According to human intaking amount's (about 40mg/kg body weight) of tortoise powder, respectively by its 10 times, 20 times, 30 times of designs it is low,
Middle and high three dosage groups, i.e. 400mg/kg body weight, 800mg/kg body weight, 1200mg/kg body weight, and distilled water are used as control
Group, daily gavage once, continuous 30 days.
1.2.1 internal organs/body weight ratio and mouse carbonic clearance test
Last to after sample 24 hours put to death mouse, weigh, take thymus gland, spleen is simultaneously weighed, calculate spleen/body weight ratio and
Spleen/body weight ratio.
1.2.2 dinitrofluorobenzene (DNFB) inducing mouse DTH (ear swelling method) is tested
Sensitization is smeared with DNFB solution after mouse part skin is lost hair or feathers to 30 days to sample, by 1%DNFB solution 10 after 5 days
μ L are applied to mouse right ear (two sides) and attacked, and mouse is put to death after 24h, take the auricle of the same position 8mm diameters of left and right ear to claim
Weight, the difference of left and right ear weight represents DTH degree.
1.2.3 the measure of serum hemolysin
Using agglutination, experiment is entered for first 5 days to every intraperitoneal injection 0.2mL2% (v/v) SRBC cell suspension of test mice
Row is immune, and last plucks eyeball to 1h after sample and takes blood, isolates serum, takes 100L to be respectively placed in Microhemagglutination plate, uses physiology salt
Water doubling dilution, then adds 100L0.5% SRBC suspensions per hole, and 3h is incubated in 37 DEG C of incubators, observes hemagglutination
Degree (0-5 grades), antibody product is gone out according to the level calculation of serum agglutination degree.
1.2.4 mouse carbonic clearance test
India ink (100mL/kg body of the last to 1h after sample through tail vein to 4 times of mouse injection normal saline dilution
Weight), timing immediately after prepared Chinese ink injection, 2min and 10min take the μ L of blood 20 from intraocular corner of the eyes veniplex respectively, are added to 2mL 0.1%
Na2CO3In solution, with Biochemical Analyzer at 600nm wavelength densitometric value (OD).Mouse is put to death simultaneously, takes liver and spleen
Weigh.Mouse carbonic clearance ability is represented with the phagocytic index a of correction.
Calculation formula is：A=body weight/(liver weight+spleen weight) × K1/3；Wherein K=(lgOD1-lgOD2)/(t2-t1)。
The immunoregulation effect result of the test of 1.3 tortoise powder is shown in Table 1-4.
Influence of the tortoise powder of table 1 to internal organs/body weight ratio
From table 1 it follows that the spleen of each dosage group of tortoise powder/body weight ratio and spleen/body weight ratio and control group are poor
It is not little, and no significant difference.
Influence of the tortoise powder of table 2 to DNFB inducing mouses DTH
From Table 2, it can be seen that the left and right ear weight difference of each dosage group mouse of tortoise powder is all higher than control group, its is low middle dose
Amount group and the difference of control group have conspicuousness (P<0.05), show that the tortoise powder that the present invention is provided can improve DNFB inducing mouse ears
Swelling degree.
Influence of the tortoise powder of table 3 to serum hemolysin
From table 3 it is observed that the antibody product of each dosage group of tortoise powder is above control group, and low middle dose group is respectively provided with
Significant difference (P ＜ 0.05), shows that tortoise powder has the serum hemolysin for improving mouse.
Influence of the tortoise powder of table 4 to carbonic clearance phagocytic index
As can be seen from Table 4, the carbonic clearance phagocytic index of each dosage group of tortoise powder is above control group (P ＜ 0.05), table
The tortoise powder that the bright present invention is provided, which has, improves the mouse monokaryon-effect of macrophage carbon corridor clearly.
In summary, the tortoise powder that the present invention is provided can improve DNFB inducing mouse ear thickness, serum hemolysin water
Flat and mouse monokaryon-macrophage carbon corridor is clear, it can be seen that, the tortoise powder that the present invention is provided has the effect of strengthen immunity.
The antifatigue effect of the tortoise powder of effect example 2
2.1 animal subject：Kunming mouse body weight 20-25g
2.2 test method：Press《Function of health food assessment process and the method for inspection》Carry out.
According to human intaking amount's (about 30mg/kg body weight) of tortoise powder, respectively by its 10 times, 20 times, 30 times of designs it is low,
Middle and high three dosage groups, i.e. 400mg/kg body weight, 800mg/kg body weight, 1200mg/kg body weight, and distilled water are used as control
Group, daily gavage once, continuous 30 days.
2.2.1 Loaned swimming test
After last is to sample 30min, the sheet lead for 5% body weight of being born a heavy burden per mouse rat-tail puts 25 DEG C of water temperature, depth of water 30-40cm water
Case went swimming, stirs water frequently, make mouse four limbs keep motion, record mouse from swim to the death time, be used as mouse
Swimming time (min).
2.2.2 blood lactase acid determination test
Last to born a heavy burden after sample 30min 2% 25-30 DEG C of temperature water went swimming, water is stirred frequently, mouse four limbs are protected
Motion is held, 60min takes out, eye blood sampling is plucked after quiet 15min.The μ L of blood 20 are taken, by method of inspection determination sample pipe and standard pipe
Optical density, measure wavelength be 560nm, calculate Serum lactic acid content.
2.2.3 serum urea nitrogen determination test
Last stirs water frequently to the water went swimming after sample 30min in 25-30 DEG C of temperature, mouse four limbs is kept motion,
90min is taken out, and eyeball blood sampling is plucked after rest 60min, takes 10 μ L serum diacetyl-oxime method urea nitrogen kit specification to survey
It is fixed.
2.2.4 hepatic glycogen is determined
Using anthrone method.After last is to sample 30min, mouse is put to death immediately, takes liver to use filter paper after being cleaned through physiological saline
Blot, be prepared into 1.0% hepatic glycogen detection liquid；Blank tube, determines pipe and standard pipe adds anthrone nitrite ion 2.mL respectively, after mixing
Put and 5min is boiled in boiling water bath, cooling colorimetric at wavelength 620nm determines each pipe OD values, calculates hepatic glycogen content.
The antifatigue effect test effect table 5-8 of 2.3 tortoise powder.
Influence of the tortoise powder of table 5 to mouse swimming time
As can be seen from Table 5, the swimming time of each dosage group mouse of tortoise powder is above control group, and poor with conspicuousness
Different (P ＜ 0.05), shows that the tortoise powder that the present invention is provided has the effect for strengthening Endurance.
Influence of the tortoise powder of table 6 to Serum lactic acid content
As can be seen from Table 6, the Serum lactic acid content of each dosage group mouse of tortoise powder is below control group, and with conspicuousness
Difference (P ＜ 0.05), shows that the tortoise powder that the present invention is provided has the effect for reducing lactic acid content.
Influence of the tortoise powder of table 7 to serum urea nitrogen content
As can be seen from Table 7, the serum urea content of each dosage group mouse of tortoise powder is below control group, and with notable
Sex differernce (P ＜ 0.05), analyze reason, it may be possible to due to tortoise powder can improve the energy matters such as body carbohydrate or fat deposit and
Utilize, so that in motion more sufficient energy can be obtained by sugar, catabolism of fat, reduce protein and amino acids
Decompose.Therefore, increase sugared, the deposit of the energy matter such as fat and utilization are probably the reason for tortoise powder is antifatigue.
Influence of the tortoise powder of table 8 to hepatic glycogen
As can be seen from Table 8, the hepatic glycogen content of each dosage group mouse of tortoise powder is above control group, and with conspicuousness
Difference (P ＜ 0.01), shows that the tortoise powder that the present invention is provided can improve mouse hepatic glycogen content, extension maintains normal glycemic levels
Time, so that the generation of delay fatigue.
According to the Ministry of Public Health《Function of health food evaluation degree and the method for inspection》The result of requirement antifatigue effect sentence
It is the positive to determine method (the containing 1) exercise test that is more than 1 and more than 2 (containing 2) biochemical indicators, that is, can determine whether the tested material
With antifatigue effect.It therefore follows that the tortoise powder that the present invention is provided has antifatigue effect.
The health-care effect of the tortoise powder of effect example 3
Experiment crowd：450 patients of inferior health are selected, age 28-65 Sui, wherein male 236, female 214, men and women has
The symptoms such as easy fatigue and weak, poor appetite, the listless, decrease of memory of same or like degree.
Test method：Random packet, every group of 50 patients, it is tortoise prepared by embodiment 1-5 that test group 1-5, which is respectively adopted,
The tortoise powder of comparative example 1-3 preparations is respectively adopted in powder, control group 1-3, and comparative example 4 uses commercially available tortoise powder, daily 2 doses of drink-services, every dose
25g, continuously takes 4 months, takes and its health-care effect is counted after 4 months, such as it is antifatigue, whet the appetite, energy is full, enhancing note
Recall power, enhancing resistance against diseases etc..
Result of the test is as shown in table 9.
The each group health-care effect of table 9
From table 9, it can be seen that the items using the test group 1-5 of the embodiment 1-5 tortoise powder prepared health-care effect refer to
Mark, it is such as antifatigue, whet the appetite, energy is full, enhancing memory, strengthen resistance against diseases, be much better than control group 1-4, explanation
The tortoise powder that the present invention is provided has antifatigue and strengthen immunity effect, and health-care effect is good.
The composition and ratio for the tortoise powder that control group 1 and control group 2 are provided is not within the scope of the present invention, its health-care effect
There is no test group 1 good, it is seen that the Chinese medicine composition that the present invention is provided is by its specific raw material to dysmenorrhoea good therapeutic effect
What component and proportioning were determined, if component and its not mutually coordinated, the beneficial effect that single component is brought, it is likely that meeting of proportioning
Cut down by other components and even eliminate, do not have whole synthesis effect.
The preparation method for the tortoise powder that control group 3 is provided is different from the preparation method that the present invention is provided, the guarantor of obtained tortoise powder
Strong effect is also not so good as embodiment 1, illustrates that preparation method has a certain impact to tortoise powder, prepared by the method provided according to the present invention
Tortoise powder, good health care effect.
Control group 4 uses commercially available tortoise powder, and its health-care effect test group 1-5 that is far from is good.
In summary, the tortoise powder that provides of the present invention is acted on by coordinated each other, reach improvement human body constitution,
Immunity, antifatigue effect are improved, health-care effect is good.
The effect for being exemplified below the tortoise powder that several model cases are provided the present invention is illustrated.
Case 1
Yan, female, 30 years old, due to often overtime work, operating pressure was big, and weak all over, skin is intensely dark, poor appetite,
Frequent fever easy to catch cold.
The tortoise powder for taking the offer of the embodiment of the present invention 1 is nursed one's health, direct Instant Drinks, twice daily, and the morning and evening is each after meal once,
50 grams every time.Take after 3 months, appetite increase, skin also improves, the state of mind recovers good, and during which cat fever etc. is raw
The number of times of disease is significantly reduced.
Case 2
Mr. Wang, female, 48 years old, weak, complexion is dark yellow, listless, poor appetite, does some works, just feels special
Not Lei, easy shortness of breath, night sweat dreaminess.
The tortoise powder that daily embodiment of the present invention 3 is provided is cooked gruel, and is nursed one's health, and 30 grams are added every time, is taken 1 month
Afterwards, also no longer as before without strength, face gain color with appetite increase, sensation；Continue to take after 2 months, face
Color is ruddy, and appetite is normal, and sleep quality improves, without symptom of getting up in the night to urinate.
Case 3
Mr. Wang, 42 years old, feels weak all over, face jaundice, blacks near the eyes yellow, energy is depressed, and decrease of memory has height
Blood pressure medical history, often can often violate.
The tortoise powder provided using the embodiment of the present invention 2 is prepared into after bread, and breakfast is eaten, and 40 grams are added every time, 2 are adhered to
After month, appetite increase, complexion improves, and from head to foot also energetically, memory increases；Continue to take after 3 months, various bad diseases
Shape disappears, and blood pressure also recovers normal, and body ＆ mind state recovers normal.
Finally it should be noted that：Various embodiments above is merely illustrative of the technical solution of the present invention, rather than its limitations；To the greatest extent
The present invention is described in detail with reference to foregoing embodiments for pipe, it will be understood by those within the art that：Its according to
The technical scheme described in foregoing embodiments can so be modified, or which part or all technical characteristic are entered
Row equivalent substitution；And these modifications or replacement, the essence of appropriate technical solution is departed from various embodiments of the present invention technology
The scope of scheme.
Claims (10)
1. a kind of tortoise powder, it is characterised in that including the following raw material counted by weight：60-80 parts of tortoise, 5-15 parts of ganoderma lucidum,
1-2 parts of 2-8 parts of the root of kudzu vine, 2-8 parts of ginger, 1-5 parts of the fruit of Chinese wolfberry, 1-3 parts of the red sage root, 1-3 parts of pseudo-ginseng, 1-3 parts of the Radix Astragali and cordyceps sinensis.
2. tortoise powder according to claim 1, it is characterised in that including the following raw material counted by weight：Tortoise 65-75
Part, 7-13 parts of ganoderma lucidum, 3-7 parts of the root of kudzu vine, 3-7 parts of ginger, 2-4 parts of the fruit of Chinese wolfberry, 1-3 parts of the red sage root, 1-3 parts of pseudo-ginseng, 1-3 parts of the Radix Astragali and
1-2 parts of cordyceps sinensis.
3. tortoise powder according to claim 2, it is characterised in that including the following raw material counted by weight：70 parts of tortoise,
1 part of 10 parts of ganoderma lucidum, 5 parts of the root of kudzu vine, 5 parts of ginger, 3 parts of the fruit of Chinese wolfberry, 2 parts of the red sage root, 2 parts of pseudo-ginseng, 2 parts of the Radix Astragali and cordyceps sinensis.
4. the preparation method of the tortoise powder as described in claim any one of 1-3, it is characterised in that comprise the following steps：
(a) tortoise living is supported 5-7 days with clear water, cleaned up, and be ground into 2-4cm fragment；
(b) powder is made in ganoderma lucidum, the root of kudzu vine, ginger, the fruit of Chinese wolfberry, the red sage root, pseudo-ginseng, the Radix Astragali and cordyceps sinensis respectively, it is standby；
(c) tortoise fragment is boiled in 95-100 DEG C of water；
(d) other raw material powder are added by weight, are boiled in 80-90 DEG C of water, are obtained dope；
(e) it is dried at 80-90 DEG C；
(f) 80-150 mesh powders are ground into by dried.
5. preparation method according to claim 4, it is characterised in that the time is boiled in step (c) for 36-48 hours.
6. preparation method according to claim 4, it is characterised in that the time is boiled in step (d) for 60-90 minutes.
7. preparation method according to claim 4, it is characterised in that drying time is 24-36 hours in step (e).
8. the preparation method according to claim any one of 4-7, it is characterised in that the powder that step (f) is made is added
Packed after preservative.
9. application of the tortoise powder as described in claim any one of 1-3 in terms of cake is prepared.
10. application of the tortoise powder as described in claim any one of 1-3 in terms of Baoshang.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710389829.9A CN107125751B (en) | 2017-05-27 | 2017-05-27 | Tortoise powder, preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710389829.9A CN107125751B (en) | 2017-05-27 | 2017-05-27 | Tortoise powder, preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107125751A true CN107125751A (en) | 2017-09-05 |
| CN107125751B CN107125751B (en) | 2021-03-09 |
Family
ID=59734820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710389829.9A Active CN107125751B (en) | 2017-05-27 | 2017-05-27 | Tortoise powder, preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107125751B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111067107A (en) * | 2018-10-19 | 2020-04-28 | 佛山市肽硒其生物科技有限公司 | Ossein tablet and processing method thereof |
| CN114982972A (en) * | 2022-06-16 | 2022-09-02 | 广州智力康生物技术有限公司 | Method for preparing qi and yin deficiency health-care capsule food by selecting blood meat poultry animal to extract high-quality protein and Chinese herbal medicines |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098604A (en) * | 1993-08-09 | 1995-02-15 | 曹永迪 | A kind of nutrient oral liquor of producing with tortoise |
| CN101380108A (en) * | 2008-09-22 | 2009-03-11 | 李素云 | Diet therapy method capable of replenishing the calcium |
| CN102100379A (en) * | 2009-12-18 | 2011-06-22 | 杨红 | Body-building strength-increasing soup |
| CN102907689A (en) * | 2011-08-01 | 2013-02-06 | 郭志永 | A preparation method for a medicinal chicken with turtle |
| CN104872661A (en) * | 2015-05-22 | 2015-09-02 | 侯根香 | Complementary therapy for improving osteoporosis |
| CN105831659A (en) * | 2016-04-14 | 2016-08-10 | 梧州市产品质量检验所 | Chinese herbal jelly having liver protection function and manufacturing method of Chinese herbal jelly |
| CN105920296A (en) * | 2016-04-29 | 2016-09-07 | 王志敏 | Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof |
| CN106490560A (en) * | 2015-09-06 | 2017-03-15 | 郑州市沃田配肥站 | A kind of qi-restoratives bone strengthening diet-therapy health-preserving meat soup formula |
-
2017
- 2017-05-27 CN CN201710389829.9A patent/CN107125751B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098604A (en) * | 1993-08-09 | 1995-02-15 | 曹永迪 | A kind of nutrient oral liquor of producing with tortoise |
| CN101380108A (en) * | 2008-09-22 | 2009-03-11 | 李素云 | Diet therapy method capable of replenishing the calcium |
| CN102100379A (en) * | 2009-12-18 | 2011-06-22 | 杨红 | Body-building strength-increasing soup |
| CN102907689A (en) * | 2011-08-01 | 2013-02-06 | 郭志永 | A preparation method for a medicinal chicken with turtle |
| CN104872661A (en) * | 2015-05-22 | 2015-09-02 | 侯根香 | Complementary therapy for improving osteoporosis |
| CN106490560A (en) * | 2015-09-06 | 2017-03-15 | 郑州市沃田配肥站 | A kind of qi-restoratives bone strengthening diet-therapy health-preserving meat soup formula |
| CN105831659A (en) * | 2016-04-14 | 2016-08-10 | 梧州市产品质量检验所 | Chinese herbal jelly having liver protection function and manufacturing method of Chinese herbal jelly |
| CN105920296A (en) * | 2016-04-29 | 2016-09-07 | 王志敏 | Traditional Chinese medicine preparation for adjuvant treatment of angina pectoris in qi-and-yin-deficiency type coronary heart diseases, and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111067107A (en) * | 2018-10-19 | 2020-04-28 | 佛山市肽硒其生物科技有限公司 | Ossein tablet and processing method thereof |
| CN114982972A (en) * | 2022-06-16 | 2022-09-02 | 广州智力康生物技术有限公司 | Method for preparing qi and yin deficiency health-care capsule food by selecting blood meat poultry animal to extract high-quality protein and Chinese herbal medicines |
| CN114982972B (en) * | 2022-06-16 | 2024-03-29 | 广州智力康生物技术有限公司 | Method for preparing qi-yin-deficiency health care capsule food by extracting high-quality protein from blood meat animals and Chinese herbal medicines |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107125751B (en) | 2021-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101695376B (en) | Health-care food for preventing diabetes | |
| CN106722963A (en) | A kind of vegetarian diet meal | |
| CN103478796A (en) | Formula of wild mushroom soup blend and production method for wild mushroom soup blend | |
| CN103859378A (en) | Formula and preparation method of life cultivation and health preservation food helpful for reducing blood sugar | |
| CN107114663A (en) | A kind of fruits and vegetables nourishing the stomach ground rice and preparation method thereof | |
| CN103859375A (en) | Formula and preparation method of life cultivation and health preservation food helpful for enhancing immunity | |
| CN105166235A (en) | Qi-blood tonifying health tea capable of reducing hyperlipidemia, hypertension and hyperglycemia and preparation method thereof | |
| CN103719491B (en) | A kind of sealwort invigorating the spleen moistening lung health protection tea and preparation method thereof | |
| CN107568718A (en) | Nigrescence color dietary fiber meal replacing food is moistened in a kind of beauty treatment | |
| CN1676036A (en) | Health-care food of glossy ganoderma and China root greenbrier rhizome and its preparing method | |
| CN103652926A (en) | Food composition for tumor patients | |
| CN103689559A (en) | Health-preserving health food formula beneficial for improving gastrointestinal functions and preparation method thereof | |
| CN107125751A (en) | Tortoise powder, preparation method and applications | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN104388263A (en) | Hawthorn/longan health-preserving traditional Chinese medicine wine and preparation method thereof | |
| CN106822660A (en) | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease | |
| CN104017701B (en) | The logical health-care white spirit of a kind of the five internal organs weighing apparatus | |
| CN103689561A (en) | Health-preserving health food formula beneficial for reducing lipid and losing weight and preparation method thereof | |
| CN106036906A (en) | Selenium-enriched kudzu root guilinggao for nourishing blood and calming nerves and preparation method thereof | |
| CN106177651A (en) | A kind of infantile malnutrition medicine | |
| CN105361149A (en) | Highland barley-Chinese caterpillar fungus nutrition powder and preparation method thereof | |
| CN105056046A (en) | Traditional Chinese medicine oral liquid for treating cold and cough and preparation method thereof | |
| CN106361982A (en) | Edible and medicinal traditional Chinese medicine preparations for treating diabetes and preparing method thereof | |
| CN106509609A (en) | Edible mushroom health care porridge | |
| CN105918902A (en) | Yak chine medicinal diet for weight reducing and whitening after childbirth and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |